[go: up one dir, main page]

CY2247B1 - Indole derivative - Google Patents

Indole derivative

Info

Publication number
CY2247B1
CY2247B1 CY0100039A CY0100039A CY2247B1 CY 2247 B1 CY2247 B1 CY 2247B1 CY 0100039 A CY0100039 A CY 0100039A CY 0100039 A CY0100039 A CY 0100039A CY 2247 B1 CY2247 B1 CY 2247B1
Authority
CY
Cyprus
Prior art keywords
lower alkoxy
alkoxy
alkoxycarbonyl
indole derivative
carboxy
Prior art date
Application number
CY0100039A
Other languages
English (en)
Inventor
Shiro Kato
Hiroshi Harada
Yoshimi Hirokawa
Naoyuki Yoshida
Hitoshi Kawashima
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of CY2247B1 publication Critical patent/CY2247B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY0100039A 1994-11-29 2001-11-20 Indole derivative CY2247B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06321402 1994-11-29

Publications (1)

Publication Number Publication Date
CY2247B1 true CY2247B1 (en) 2003-07-04

Family

ID=18132155

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0100039A CY2247B1 (en) 1994-11-29 2001-11-20 Indole derivative

Country Status (28)

Country Link
US (1) US5817689A (fr)
EP (1) EP0801059B1 (fr)
JP (1) JP3100165B2 (fr)
KR (1) KR100388747B1 (fr)
CN (1) CN1070477C (fr)
AT (1) ATE202559T1 (fr)
AU (1) AU688165B2 (fr)
BR (1) BR9509827A (fr)
CA (1) CA2206307A1 (fr)
CY (1) CY2247B1 (fr)
CZ (1) CZ290871B6 (fr)
DE (1) DE69521529T2 (fr)
DK (1) DK0801059T3 (fr)
ES (1) ES2159648T3 (fr)
FI (1) FI972275A0 (fr)
GR (1) GR3036148T3 (fr)
HU (1) HUT77308A (fr)
IL (1) IL116178A (fr)
NO (1) NO309648B1 (fr)
NZ (1) NZ295749A (fr)
PL (1) PL181963B1 (fr)
PT (1) PT801059E (fr)
RO (1) RO118426B1 (fr)
RU (1) RU2137759C1 (fr)
SK (1) SK281865B6 (fr)
TW (1) TW349091B (fr)
WO (1) WO1996016938A1 (fr)
ZA (1) ZA9510130B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010580A1 (es) * 1999-09-03 2001-05-25 Takeda Chemical Industries Ltd Composicion farmaceutica para tratar la diabetes
CA2391646A1 (fr) * 1999-11-30 2001-06-07 Dainippon Pharmaceutical Co., Ltd. Preparation solide
US6458824B1 (en) * 1999-11-30 2002-10-01 Dainippon Pharmaceutical Co., Ltd. Solid preparation
JP2004331500A (ja) * 2001-02-16 2004-11-25 Dainippon Pharmaceut Co Ltd 血中濃度制御製剤
EP2335700A1 (fr) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
AU2003225277A1 (en) * 2002-05-02 2003-11-17 Robert Harris Lipid removal from the body
JPWO2003106418A1 (ja) * 2002-06-12 2005-10-13 住友製薬株式会社 インドール、インダゾール、およびベンズアゾール類
PT1599468E (pt) * 2003-01-14 2008-01-14 Arena Pharm Inc Derivados de arilo e heteroarilo 1,2,3.-trissubstituídos comomoduladores do metabolismo, e profilaxia e tratamento dedesordens relacionadas tais como diabetes e hiperglicemia
SI1599468T1 (sl) * 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-trisubstituirani arilni in heteroarilni derivati kot modulatorji metabolizma ter profilaksa in zdravljenje motenj v zvezi z njim, kot diabetesain hiperglikemije
US7223785B2 (en) * 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
WO2004089936A1 (fr) * 2003-04-10 2004-10-21 Dainippon Pharmaceutical Co., Ltd. Derive d'heteroarylsulfonanilide et composition pharmaceutique le contenant
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
WO2005051298A2 (fr) * 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Nouvelles substances thyromimetiques contenant du phosphore
SG184700A1 (en) 2004-02-20 2012-10-30 Boehringer Ingelheim Int Viral polymerase inhibitors
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
CA2618682C (fr) * 2005-08-12 2011-06-21 Boehringer Ingelheim International Gmbh Inhibiteurs de polymerase virale
JP5941916B2 (ja) 2010-09-22 2016-06-29 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｇｐｒ１１９レセプターのモジュレーターおよびそれに関連する障害の処置
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar
WO2015199097A1 (fr) * 2014-06-24 2015-12-30 花王株式会社 Promoteur de l'expression d'ucp-1
JP6660668B2 (ja) * 2014-06-24 2020-03-11 花王株式会社 Ｕｃｐ−１発現促進剤
US10758519B2 (en) 2014-06-24 2020-09-01 Kao Corporation UCP-1 expression promoter
PL3242666T3 (pl) 2015-01-06 2025-02-17 Arena Pharmaceuticals, Inc. Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
DK3310760T3 (da) 2015-06-22 2022-10-24 Arena Pharm Inc Krystallinsk L-argininsalt af (R)-2-(7-(4-cyclopentyl-3-(trifluormethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3- yl)eddikesyre til anvendelse ved S1P1-receptor-associerede lidelser
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB861428A (en) * 1958-07-14 1961-02-22 Searle & Co Improvements in or relating to indole derivatives
US4055658A (en) * 1976-05-17 1977-10-25 Mead Johnson & Company Cyanomethylphenethanolamines
EP0023385B1 (fr) * 1979-06-16 1982-12-15 Beecham Group Plc Dérivés d'éthanamines, leur préparation et leur utilisation dans des compositions pharmaceutiques
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
JPH06345731A (ja) * 1992-04-28 1994-12-20 Dainippon Pharmaceut Co Ltd ２−〔２−（インドール−３−イル）エチルアミノ〕−１−フェニルエタノール誘導体
JPH0634531A (ja) * 1992-07-14 1994-02-08 Yokogawa Electric Corp 赤外線水分計

Also Published As

Publication number Publication date
BR9509827A (pt) 1997-09-30
CZ165597A3 (en) 1997-11-12
DE69521529T2 (de) 2001-10-11
IL116178A (en) 2000-07-26
HUT77308A (hu) 1998-03-30
CA2206307A1 (fr) 1996-06-06
FI972275A7 (fi) 1997-05-29
WO1996016938A1 (fr) 1996-06-06
ES2159648T3 (es) 2001-10-16
NO972427D0 (no) 1997-05-28
PL320461A1 (en) 1997-09-29
EP0801059B1 (fr) 2001-06-27
NO972427L (no) 1997-07-28
PT801059E (pt) 2001-10-30
RU2137759C1 (ru) 1999-09-20
CZ290871B6 (cs) 2002-11-13
HK1003886A1 (en) 1998-11-13
DE69521529D1 (de) 2001-08-02
FI972275L (fi) 1997-05-29
TW349091B (en) 1999-01-01
RO118426B1 (ro) 2003-05-30
AU3936695A (en) 1996-06-19
DK0801059T3 (da) 2001-09-24
CN1174549A (zh) 1998-02-25
ATE202559T1 (de) 2001-07-15
SK281865B6 (sk) 2001-08-06
MX9703858A (es) 1997-09-30
JP3100165B2 (ja) 2000-10-16
CN1070477C (zh) 2001-09-05
NO309648B1 (no) 2001-03-05
SK65697A3 (en) 1998-01-14
AU688165B2 (en) 1998-03-05
NZ295749A (en) 1998-05-27
EP0801059A1 (fr) 1997-10-15
EP0801059A4 (fr) 1998-01-21
GR3036148T3 (en) 2001-09-28
FI972275A0 (fi) 1997-05-29
ZA9510130B (en) 1996-06-11
KR100388747B1 (ko) 2004-03-30
PL181963B1 (pl) 2001-10-31
US5817689A (en) 1998-10-06
IL116178A0 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
GR3036148T3 (en) Indole derivative
AU573018B2 (en) 11-substituted 16-phenoxy prostatrienoic acid derivatives
HU9302530D0 (en) Herbicidal pyridinesulphonamide compounds
ATE172463T1 (de) Pyrrolocarbazol
IL118368A0 (en) N-oxide heteroaroyl derivatives
YU45423B (en) Process for obtaining heterocyclical benzene derivatives
DE69222459D1 (de) Thiazolidindionderivate, ihre Herstellung und Anwendung
ATE231487T1 (de) 2-phenoxyanilin-derivate
DK603789A (da) Substituerede imidazolderivater og fremstilling og anvendelse deraf
EP0889033A4 (fr)
AU6063298A (en) Benzamide derivative, anti-ulcer drug, and antibacterial drug
IL95377A0 (en) Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type
GR3025405T3 (en) Bicyclic oxazole and thiazole substituted ethers
ZA812541B (en) Benzothiazole derivatives and salts thereof,processes for their preparation,and their use as sweetening agents
GR3022628T3 (en) Heterocyclic derivatives of alkoxyacrylates with fungicidal activity
CA2258960A1 (fr) Procede de preparation de naphtyridones et de leurs intermediaires
AU650630B2 (en) Novel benzoxazolone compounds and the use thereof as microbicides
GB8700748D0 (en) Preparation of heterocyclic compounds
GR3030952T3 (en) Salmycins, a process for their preparation and their use as a pharmaceutical.